Biopharma firms must diversify CDMO partnerships to avoid costly delays: Shilpa Biologicals MD
Madhav Bhutada says overdependence on large CDMOs and delayed engagement can increase development costs by up to 40% and slow clinical progress
Madhav Bhutada says overdependence on large CDMOs and delayed engagement can increase development costs by up to 40% and slow clinical progress
Company launches clinical study of AI-designed oral formulation following MHRA approval, marking a major milestone in AI-driven drug development.
The new facility marks Align’s first manufacturing presence in India and its fourth globally
India already has talent, digital infrastructure, entrepreneurial energy, clinical expertise, and policy momentum. The next phase demands coordinated execution and building institutions that can hold the ecosystem together over time
A one-shot gene-editing cholesterol therapy could soon be a reality
Fresh data from the State of the World’s Nursing 2025 report shows the global nursing workforce has expanded from 27.9 million in 2018 to 29.8 million in 2023
The company is expected to conduct further studies to confirm the long-term efficacy and safety of Vijoice in both adult and paediatric patients
Revenue from operations climbed 13% to Rs. 886.87 crore
Across more than 85 abstracts, AstraZeneca will showcase 10 approved medicines and 13 potential new therapies
More than 450 public and private health technology solutions have integrated with the Ayushman Bharat Digital Mission ecosystem
Subscribe To Our Newsletter & Stay Updated